Literature DB >> 6827099

Automated production of monoclonal antibodies in a cytostat.

S Fazekas de St Groth.   

Abstract

Suspension cultures of B cell hybridomas can be maintained in exponential growth, by matching their rate of replication with the input of medium. A cytostat has been designed to perform this operation automatically. The conditions of cytostatic growth were tested on a panel of 10 hybridomas, representing a range of growth rates, specificities, affinities, quantities and types of globulins produced. No special media were needed, but it was necessary to shield the cells from light and stir them at rates lower than 60 rpm. The rate of multiplication is, on average, 15% slower than in stationary cultures, but the cells reach almost twice the concentration. The yield of immunoglobulin is a direct function of the number of live cells and does not depend on their rate growth. All cell lines grew well in serum-free medium and produced the equivalent of 50 standard tissue culture bottles each day, for period of several weeks.

Mesh:

Substances:

Year:  1983        PMID: 6827099     DOI: 10.1016/0022-1759(83)90070-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

Review 1.  Serum-free medium for fermentor cultures of hybridomas.

Authors:  O W Merten; J Litwin
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

2.  A comparison of different culture methods for hybridoma propagation and monoclonal antibody production.

Authors:  C P Marquis; C Harbour; J P Barford; K S Low
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

3.  Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures.

Authors:  M al-Rubeai; A N Emery; S Chalder; D C Jan
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 4.  An analysis of some batch and continuous kinetic data of specific monoclonal antibody production from hybridomas.

Authors:  P J Phillips; C P Marquis; J P Barford; C Harbour
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

5.  Batch production and growth kinetics of hybridomas.

Authors:  O W Merten
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

6.  Influence of bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma.

Authors:  D Fassnacht; S Rössing; R P Singh; M Al-Rubeai; R Pörtner
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

7.  Variable functions of bcl-2 in mediating bioreactor stress- induced apoptosis in hybridoma cells.

Authors:  A Perani; R P Singh; R Chauhan; M Al-Rubeai
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

8.  Substitution of transferrin by FeCl3 in the development of a low foetal calf serum concentration medium for KB-26.5 hybridoma cell line.

Authors:  B Damgaard; A Sanfeliu; J J Cairó; C Casas; C Solà; F Gòdia
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 9.  Antibody engineering, a strategy for the development of monoclonal antibodies.

Authors:  O T Schönherr; E H Houwink
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

10.  A cystic fibrosis pancreatic adenocarcinoma cell line.

Authors:  R A Schoumacher; J Ram; M C Iannuzzi; N A Bradbury; R W Wallace; C T Hon; D R Kelly; S M Schmid; F B Gelder; T A Rado
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.